Lesch-Nyhan Syndrome: Models, Theories, and Therapies.
|Title||Lesch-Nyhan Syndrome: Models, Theories, and Therapies.|
|Publication Type||Journal Article|
|Year of Publication||2016|
|Authors||Bell S, Kolobova I, Crapper L, Ernst C|
|Date Published||2016 Nov|
Lesch-Nyhan syndrome (LNS) is a rare X-linked disorder caused by mutations in HPRT1, an important enzyme in the purine salvage pathway. Symptoms of LNS include dystonia, gout, intellectual disability, and self-mutilation. Despite having been characterized over 50 years ago, it remains unclear precisely how deficits in hypoxanthine and guanine recycling can lead to such a profound neurological phenotype. Several studies have proposed different hypotheses regarding the etiology of this disease, and several treatments have been tried in patients, though none have led to a satisfactory explanation of the disease. New technologies such as next-generation sequencing, optogenetics, genome editing, and induced pluripotent stem cells provide a unique opportunity to map the precise sequential pathways leading from genotype to phenotype.
|Alternate Journal||Mol Syndromol|
|PubMed Central ID||PMC5131334|